Download this PDF file
Crossref Citations
1. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings
A. D. Ware, C. Jacquot, A. A. R. Tobian, E. A. Gehrie, P. M. Ness, E. M. Bloch
Vox Sanguinis vol: 113 issue: 1 first page: 3 year: 2018
doi: 10.1111/vox.12620
2. Progress towards an appropriate pathogen reduction technology for whole blood in Africa
Soraya Amar El Dusouqui, Marion C. Lanteri, Rudolf Schwabe, Anja Grzesiczek, Anne North, Nina Mufti, Yassongui Mamadou Sekongo, John Pitman, Claude Tayou Tagny
ISBT Science Series vol: 15 issue: 1 first page: 151 year: 2020
doi: 10.1111/voxs.12524
3. Effects of Whole Blood Storage on Hematological Parameters of Sudanese Donors attending Central Blood Bank
Abdalla M. Abdalla, Emad A. Nourelgalil, May Mohammed Ali, Tarig A. M. Hamid
European Journal of Theoretical and Applied Sciences vol: 2 issue: 6 first page: 943 year: 2024
doi: 10.59324/ejtas.2024.2(6).83
4. Effects of an amustaline (S‐303)/glutathione pathogen reduction system on the in vitro quality of plasma and platelets in treated whole blood
M. Reza Khoshi, Ayantu Jinfessa, Anais Pongerard, Michelle Gatmaitan, Melanie Sweeney, Anna Lavrentieva, Cliff Hayashi, Bryan J. Visser, Nina Mufti, Sanjai Kumar, David R. McGivern, Jan Simak, Subramanian Yegneswaran, Carlos H. Villa
Transfusion vol: 66 issue: 1 first page: 187 year: 2026
doi: 10.1111/trf.18484
5. Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy
Karen Bieback, Beatriz Fernandez‐Muñoz, Shibani Pati, Richard Schäfer
Transfusion vol: 59 issue: 11 first page: 3448 year: 2019
doi: 10.1111/trf.15483
6. Zika virus and blood transfusion: the experience of French Polynesia
Damien Bierlaire, Sylvie Mauguin, Julien Broult, Didier Musso
Transfusion vol: 57 issue: 3pt2 first page: 729 year: 2017
doi: 10.1111/trf.14028
7. Blood transfusion in sub‐Saharan Africa: understanding the missing gap and responding to present and future challenges
Lassina Barro, Victor J. Drew, Ghislain G. Poda, Claude T. Tagny, Magdy El‐Ekiaby, Shirley Owusu‐Ofori, Thierry Burnouf
Vox Sanguinis vol: 113 issue: 8 first page: 726 year: 2018
doi: 10.1111/vox.12705
8. Prevention of transfusion‐transmitted Zika virus in French Polynesia, nucleic acid testing versus pathogen inactivation
D. Musso, J. Broult, D. Bierlaire, M. C. Lanteri, M. Aubry
ISBT Science Series vol: 12 issue: 1 first page: 254 year: 2017
doi: 10.1111/voxs.12335
9. Amustaline (S‐303) treatment inactivates high levels of Zika virus in red blood cell components
Andrew Laughhunn, Felicia Santa Maria, Julien Broult, Marion C. Lanteri, Adonis Stassinopoulos, Didier Musso, Maite Aubry
Transfusion vol: 57 issue: 3pt2 first page: 779 year: 2017
doi: 10.1111/trf.13993
10. Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy
KAREN Bieback, BEATRIZ FERNANDEZ-MUÑOZ, SHIBANI PATI, RICHARD SCHÄFER
Cytotherapy vol: 21 issue: 9 first page: 911 year: 2019
doi: 10.1016/j.jcyt.2019.06.006
11. Transfusion in limited infrastructure locations – where to go decades after safe blood initiative by World Health Organization?
Angela Ugwu, Dalha Gwarzo, Theresa Nwagha, Aisha Gwarzo, Andreas Greinacher
ISBT Science Series vol: 15 issue: 1 first page: 118 year: 2020
doi: 10.1111/voxs.12519
12. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)
Chintamani Atreya, Simone Glynn, Michael Busch, Steve Kleinman, Edward Snyder, Sara Rutter, James AuBuchon, Willy Flegel, David Reeve, Dana Devine, Claudia Cohn, Brian Custer, Raymond Goodrich, Richard J. Benjamin, Anna Razatos, Jose Cancelas, Stephen Wagner, Michelle Maclean, Monique Gelderman, Andrew Cap, Paul Ness
Transfusion vol: 59 issue: 9 first page: 3002 year: 2019
doi: 10.1111/trf.15344
